| Product Code: ETC7539290 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In 2024, India`s import of cardiotonic agents continued to be dominated by key players such as the USA, China, and Canada. The high Herfindahl-Hirschman Index (HHI) indicates a concentrated market, potentially leading to pricing power for exporters. Despite a modest Compound Annual Growth Rate (CAGR) of 0.43% from 2020 to 2024, the impressive growth rate of 14.04% from 2023 to 2024 suggests a positive uptick in demand for cardiotonic agents in the Indian market. This trend underscores opportunities for market players to capitalize on the growing demand for cardiovascular health products in India.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 India Cardiotonic Agents Market Overview |
3.1 India Country Macro Economic Indicators |
3.2 India Cardiotonic Agents Market Revenues & Volume, 2021 & 2031F |
3.3 India Cardiotonic Agents Market - Industry Life Cycle |
3.4 India Cardiotonic Agents Market - Porter's Five Forces |
3.5 India Cardiotonic Agents Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.6 India Cardiotonic Agents Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.7 India Cardiotonic Agents Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 India Cardiotonic Agents Market Revenues & Volume Share, By Dosage Form, 2021 & 2031F |
3.9 India Cardiotonic Agents Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 India Cardiotonic Agents Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cardiovascular diseases in India |
4.2.2 Growing awareness about the importance of cardiac health |
4.2.3 Rising geriatric population in the country |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for drug approvals |
4.3.2 High competition among existing cardiotonic agents in the market |
4.3.3 Economic instability affecting healthcare spending in India |
5 India Cardiotonic Agents Market Trends |
6 India Cardiotonic Agents Market, By Types |
6.1 India Cardiotonic Agents Market, By Drug Type |
6.1.1 Overview and Analysis |
6.1.2 India Cardiotonic Agents Market Revenues & Volume, By Drug Type, 2021- 2031F |
6.1.3 India Cardiotonic Agents Market Revenues & Volume, By Digitalis Glycosides, 2021- 2031F |
6.1.4 India Cardiotonic Agents Market Revenues & Volume, By Phosphodiesterase Inhibitors, 2021- 2031F |
6.1.5 India Cardiotonic Agents Market Revenues & Volume, By Cardioprotectants, 2021- 2031F |
6.1.6 India Cardiotonic Agents Market Revenues & Volume, By Sympathomimetic Agents, 2021- 2031F |
6.1.7 India Cardiotonic Agents Market Revenues & Volume, By Others, 2021- 2031F |
6.2 India Cardiotonic Agents Market, By Application |
6.2.1 Overview and Analysis |
6.2.2 India Cardiotonic Agents Market Revenues & Volume, By Cardiac Surgical Procedures, 2021- 2031F |
6.2.3 India Cardiotonic Agents Market Revenues & Volume, By Atrial Fibrillation, 2021- 2031F |
6.2.4 India Cardiotonic Agents Market Revenues & Volume, By Heart Failure, 2021- 2031F |
6.2.5 India Cardiotonic Agents Market Revenues & Volume, By Pulmonary Hypertension, 2021- 2031F |
6.2.6 India Cardiotonic Agents Market Revenues & Volume, By Others (Atrial Flutter, Cardiogenic Shock, etc.), 2021- 2031F |
6.3 India Cardiotonic Agents Market, By Route of Administration |
6.3.1 Overview and Analysis |
6.3.2 India Cardiotonic Agents Market Revenues & Volume, By Oral, 2021- 2031F |
6.3.3 India Cardiotonic Agents Market Revenues & Volume, By Parenteral, 2021- 2031F |
6.4 India Cardiotonic Agents Market, By Dosage Form |
6.4.1 Overview and Analysis |
6.4.2 India Cardiotonic Agents Market Revenues & Volume, By Tablet, 2021- 2031F |
6.4.3 India Cardiotonic Agents Market Revenues & Volume, By Solution, 2021- 2031F |
6.4.4 India Cardiotonic Agents Market Revenues & Volume, By Others, 2021- 2031F |
6.5 India Cardiotonic Agents Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 India Cardiotonic Agents Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 India Cardiotonic Agents Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 India Cardiotonic Agents Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
7 India Cardiotonic Agents Market Import-Export Trade Statistics |
7.1 India Cardiotonic Agents Market Export to Major Countries |
7.2 India Cardiotonic Agents Market Imports from Major Countries |
8 India Cardiotonic Agents Market Key Performance Indicators |
8.1 Number of prescriptions for cardiotonic agents |
8.2 Patient adherence rate to cardiotonic agent treatment |
8.3 Rate of new product development in the cardiotonic agents market |
9 India Cardiotonic Agents Market - Opportunity Assessment |
9.1 India Cardiotonic Agents Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.2 India Cardiotonic Agents Market Opportunity Assessment, By Application, 2021 & 2031F |
9.3 India Cardiotonic Agents Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
9.4 India Cardiotonic Agents Market Opportunity Assessment, By Dosage Form, 2021 & 2031F |
9.5 India Cardiotonic Agents Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
10 India Cardiotonic Agents Market - Competitive Landscape |
10.1 India Cardiotonic Agents Market Revenue Share, By Companies, 2024 |
10.2 India Cardiotonic Agents Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here